Science Review Links GLP-1 Drugs to Lower Dementia Risk
A new review in Science finds GLP-1 drugs like semaglutide and tirzepatide are linked to lower dementia risk in people with diabetes, but two large trials showed semaglutide did not slow early Alzheimer’s disease.